Theravance Inc (NASDAQ:THRX)

18.10
BATS BZX Real-Time Price
As of 10:50am ET
 +0.01 / +0.06%
Today’s Change
10.58
Today|||52-Week Range
31.80
+27.92%
Year-to-Date

Today’s Trading

Previous close18.09
Today’s open18.11
Day’s range18.01 - 18.27
Volume110,792
Average volume (3 months)985,413
Market cap$2.1B
Dividend yield5.53%
Data as of 10:35am ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+91.00%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)+77.24%
P/E ratioNM
Price/Sales188.03
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...-0.86-1.42%
ASPXAuspex Pharmaceutica...-2.91-4.14%
RAREUltragenyx Pharmaceu...-1.46-2.59%
IRWDIronwood Pharmaceuti...-0.31-1.93%
Data as of 10:48am ET, 02/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$8.4M
Annual profit (last year)-$168.5M
Net profit margin-871.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account